{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:29:13Z","timestamp":1761488953362,"version":"build-2065373602"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1053\/j.ajkd.2012.06.004","type":"journal-article","created":{"date-parts":[[2012,7,10]],"date-time":"2012-07-10T16:01:00Z","timestamp":1341936060000},"page":"22-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cost-Effectiveness of Latent Tuberculosis Screening Before Steroid Therapy for Idiopathic Nephrotic Syndrome in Children"],"prefix":"10.1053","volume":"61","author":[{"given":"Benjamin L.","family":"Laskin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Starke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel P.","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Eckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.ajkd.2012.06.004_bib1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1164\/rccm.2508001","article-title":"Controlling tuberculosis in the United States","volume":"172","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.004_bib3","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1542\/peds.2010-1725","article-title":"Comparing the tuberculin skin test and T-SPOT.TB blood test in children","volume":"127","author":"Cruz","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.004_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada","volume":"137","author":"Horsburgh","year":"2010","journal-title":"Chest"},{"issue":"RR-5","key":"10.1053\/j.ajkd.2012.06.004_bib5","first-page":"1","article-title":"Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"4, pt 3","key":"10.1053\/j.ajkd.2012.06.004_bib6","first-page":"1175","article-title":"Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.004_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1542\/pir.31.1.13","article-title":"Pediatric tuberculosis","volume":"31","author":"Cruz","year":"2010","journal-title":"Pediatr Rev"},{"issue":"7","key":"10.1053\/j.ajkd.2012.06.004_bib8","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies Registry","volume":"60","author":"Tubach","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.004_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"10.1053\/j.ajkd.2012.06.004_bib11","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.ajkd.2012.06.004_bib12","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1177\/106002809603001115","article-title":"Corticosteroids in tuberculosis","volume":"30","author":"Cisneros","year":"1996","journal-title":"Ann Pharmacother"},{"issue":"4, pt 2","key":"10.1053\/j.ajkd.2012.06.004_bib13","first-page":"S221","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med."},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.004_bib14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis?","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.004_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2008-1559","article-title":"Management of childhood onset nephrotic syndrome","volume":"124","author":"Gipson","year":"2009","journal-title":"Pediatrics"},{"key":"10.1053\/j.ajkd.2012.06.004_bib16","series-title":"Comprehensive Pediatric Nephrology","first-page":"205","article-title":"Nephrotic syndrome","author":"Gbadegesin","year":"2008"},{"key":"10.1053\/j.ajkd.2012.06.004_bib17","series-title":"Comprehensive Pediatric Nephrology","first-page":"239","article-title":"Steroid-sensitive nephrotic syndrome","author":"Hodson","year":"2008"},{"issue":"10","key":"10.1053\/j.ajkd.2012.06.004_bib18","first-page":"931","article-title":"Causes and costs of hospitalization of tuberculosis patients in the United States","volume":"4","author":"Taylor","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2012.06.004_bib19","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00467-005-1968-8","article-title":"Evidence-based management of steroid-sensitive nephrotic syndrome","volume":"20","author":"Hodson","year":"2005","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.004_bib20","first-page":"23","article-title":"Tuberculin reactivity in a pediatric population with high BCG vaccination coverage","volume":"3","author":"Lockman","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.004_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOP.0b013e3283350301","article-title":"Interferon-gamma release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children","volume":"22","author":"Lewinsohn","year":"2010","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.004_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Making"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/519266","article-title":"Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis","volume":"45","author":"Detjen","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.004_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archinternmed.2008.524","article-title":"Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers","volume":"169","author":"de Perio","year":"2009","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jclinepi.2009.04.008","article-title":"A statistical method was used for the meta-analysis of tests for latent TB in the absence of a gold standard, combining random-effect and latent-class methods to estimate test accuracy","volume":"63","author":"Sadatsafavi","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.ajkd.2012.06.004_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis","volume":"10","author":"Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.004_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1542\/peds.2006-2168","article-title":"Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry","volume":"120","author":"Flaherman","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.004_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib30","first-page":"310","article-title":"Tuberculin skin test: estimation of positive and negative predictive values from routine data","volume":"9","author":"Berkel","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2012.06.004_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF02602749","article-title":"Interpretation of the tuberculin skin test","volume":"10","author":"Rose","year":"1995","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2012.06.004_bib32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","article-title":"The tuberculin skin test","volume":"17","author":"Huebner","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.004_bib33","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1542\/peds.107.4.e54","article-title":"Targeted testing of children for tuberculosis: validation of a risk assessment questionnaire","volume":"107","author":"Froehlich","year":"2001","journal-title":"Pediatrics"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.004_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.285.4.451","article-title":"Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children","volume":"285","author":"Ozuah","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.004_bib35","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"issue":"14","key":"10.1053\/j.ajkd.2012.06.004_bib36","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/archinternmed.2009.211","article-title":"Cost-effectiveness of tuberculosis screening in health care workers is not robust [letter]","volume":"169","author":"Mancuso","year":"2009","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1164\/rccm.200701-057OC","article-title":"Prevalence of tuberculosis infection in the United States population: the National Health and Nutrition Examination Survey, 1999-2000","volume":"177","author":"Bennett","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1053\/j.ajkd.2012.06.004_bib38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jama.1995.03530080029037","article-title":"School-based screening for tuberculous infection","volume":"274","author":"Mohle-Boetani","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.004_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1542\/peds.98.1.97","article-title":"Tuberculin skin test screening in schoolchildren in the United States","volume":"98","author":"Driver","year":"1996","journal-title":"Pediatrics"},{"issue":"4, pt 1","key":"10.1053\/j.ajkd.2012.06.004_bib40","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1542\/peds.111.4.e309","article-title":"Tuberculin testing and risk of tuberculosis infection among New York City schoolchildren","volume":"111","author":"Gounder","year":"2003","journal-title":"Pediatrics."},{"issue":"6","key":"10.1053\/j.ajkd.2012.06.004_bib41","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1164\/ajrccm.158.6.9804106","article-title":"Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis","volume":"158","author":"Lobato","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.004_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.004_bib43","first-page":"9","article-title":"Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population","volume":"16","author":"Kim","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1467-842X.2000.tb01564.x","article-title":"Cost effectiveness analysis of school based Mantoux screening for TB infection","volume":"24","author":"Lowin","year":"2000","journal-title":"Aust N Z J Public Health"},{"issue":"8","key":"10.1053\/j.ajkd.2012.06.004_bib45","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1164\/rccm.200510-1563OC","article-title":"The scope and impact of treatment of latent tuberculosis infection in the United States and Canada","volume":"173","author":"Sterling","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.004_bib46","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","year":"1982","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.004_bib47","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/427802","article-title":"Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis","volume":"40","author":"Ena","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.004_bib48","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","article-title":"Priorities for screening and treatment of latent tuberculosis infection in the United States","volume":"184","author":"Linas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.004_bib49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2005.03.050","article-title":"Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome","volume":"147","author":"Ruth","year":"2005","journal-title":"J Pediatr"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.004_bib50","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children","volume":"8","author":"Tarshish","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.004_bib52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-150-2-200901200-00005","article-title":"Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation","volume":"150","author":"Eckman","year":"2009","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1053\/j.ajkd.2012.06.004_bib53","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/archinte.1996.00440150083009","article-title":"The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life","volume":"156","author":"Gage","year":"1996","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1053\/j.ajkd.2012.06.004_bib54","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1524-4733.2008.00355.x","article-title":"Health state utilities in latent and active tuberculosis","volume":"11","author":"Guo","year":"2008","journal-title":"Value Health"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.004_bib55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1164\/ajrccm\/137.1.215","article-title":"Isoniazid for the tuberculin reactor: take it or leave it","volume":"137","author":"Tsevat","year":"1988","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.004_bib56","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ki.1994.158","article-title":"Therapy for idiopathic membranous nephropathy: tailoring the choice by decision analysis","volume":"45","author":"Piccoli","year":"1994","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib58","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1542\/peds.2008-0433","article-title":"Latent tuberculosis infection in children: a call for revised treatment guidelines","volume":"123","author":"Finnell","year":"2009","journal-title":"Pediatrics"},{"issue":"7","key":"10.1053\/j.ajkd.2012.06.004_bib59","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archpedi.1996.02170320068011","article-title":"Screening for tuberculosis infection in urban children","volume":"150","author":"Christy","year":"1996","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"12","key":"10.1053\/j.ajkd.2012.06.004_bib60","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/502343","article-title":"Screening and treatment of latent tuberculosis among healthcare workers at low, moderate, and high risk for tuberculosis exposure: a cost-effectiveness analysis","volume":"25","author":"Salpeter","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1053\/j.ajkd.2012.06.004_bib61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2334-6-47","article-title":"Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay","volume":"6","author":"Dewan","year":"2006","journal-title":"BMC Infect Dis"},{"article-title":"Statistics on hospital stays","year":"2009","series-title":"Red Book 2009: Pharmacy's Fundamental Reference","key":"10.1053\/j.ajkd.2012.06.004_bib62"},{"issue":"12","key":"10.1053\/j.ajkd.2012.06.004_bib64","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.7326\/0003-4819-127-12-199712150-00001","article-title":"Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis","volume":"127","author":"Salpeter","year":"1997","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1053\/j.ajkd.2012.06.004_bib65","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta11210","article-title":"The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review","volume":"11","author":"Colquitt","year":"2007","journal-title":"Health Technol Assess"},{"issue":"20","key":"10.1053\/j.ajkd.2012.06.004_bib66","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib67","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1164\/rccm.200909-1355OC","article-title":"Revisiting rates of reactivation tuberculosis: a population-based approach","volume":"182","author":"Horsburgh","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1053\/j.ajkd.2012.06.004_bib68","first-page":"1226","article-title":"Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States","volume":"14","author":"LoBue","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2012.06.004_bib69","first-page":"767","article-title":"Residual lung damage after completion of treatment for multidrug-resistant tuberculosis","volume":"8","author":"de Valliere","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib70","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/003335491012500307","article-title":"Trends in tuberculosis mortality in the United States, 1990-2006: a population-based case-control study","volume":"125","author":"Jung","year":"2010","journal-title":"Public Health Rep"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","article-title":"Steroid-sensitive nephrotic syndrome: from childhood to adulthood","volume":"41","author":"Fakhouri","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.004_bib73","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJM197507312930501","article-title":"Primer on certain elements of medical decision making","volume":"293","author":"McNeil","year":"1975","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1053\/j.ajkd.2012.06.004_bib74","first-page":"1","article-title":"United States Life Tables, 2001","volume":"52","author":"Arias","year":"2004","journal-title":"Natl Vital Stat Rep"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.004_bib75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0272989X8500500205","article-title":"Probabilistic sensitivity analysis using Monte Carlo simulation","volume":"5","author":"Doubilet","year":"1985","journal-title":"Med Decis Making"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.004_bib76","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00006454-198509000-00007","article-title":"Tuberculin skin test reactivity and conversions in United States- and foreign-born Latino children","volume":"4","author":"Perez-Stable","year":"1985","journal-title":"Pediatr Infect Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2012.06.004_bib77","first-page":"406","article-title":"Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa","volume":"14","author":"Wood","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2012.06.004_bib78","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1378\/chest.06-2728","article-title":"Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany","volume":"131","author":"Diel","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1053\/j.ajkd.2012.06.004_bib79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1183\/09031936.00145906","article-title":"Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis","volume":"30","author":"Diel","year":"2007","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1053\/j.ajkd.2012.06.004_bib80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester","year":"2011","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1053\/j.ajkd.2012.06.004_bib81","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/INF.0b013e318214b915","article-title":"The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis","volume":"30","author":"Machingaidze","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1053\/j.ajkd.2012.06.004_bib82","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1542\/peds.2008-1722","article-title":"Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents","volume":"123","author":"Bergamini","year":"2009","journal-title":"Pediatrics"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861200858X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861200858X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:59:22Z","timestamp":1759456762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263861200858X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S027263861200858X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2012.06.004","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Latent Tuberculosis Screening Before Steroid Therapy for Idiopathic Nephrotic Syndrome in Children","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2012.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}